These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 35763437)
21. Risk factors for the development of acne in healthcare workers during the COVID-19 pandemic. Dani A; Eseonu A; Bibee K Arch Dermatol Res; 2023 May; 315(4):1067-1070. PubMed ID: 36357553 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of short contact therapy with tretinoin, clindamycin, and glycolic acid gel in acne: A randomized, controlled, assessor-blinded two-center trial: The MASCOTTE study. Bertolani MB; Rodighiero E; Gandolfi M; Lotti T; Pedrazzi G; Puviani M; Milani M; Feliciani C; Satolli F Dermatol Ther; 2021 Jan; 34(1):e14724. PubMed ID: 33377285 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821 [TBL] [Abstract][Full Text] [Related]
24. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Hörfelt C; Funk J; Frohm-Nilsson M; Wiegleb Edström D; Wennberg AM Br J Dermatol; 2006 Sep; 155(3):608-13. PubMed ID: 16911289 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. Wheeland RG; Dhawan S J Drugs Dermatol; 2011 Jun; 10(6):596-602. PubMed ID: 21637900 [TBL] [Abstract][Full Text] [Related]
26. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris. Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials. Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997 [TBL] [Abstract][Full Text] [Related]
28. Maskne: A New Acne Variant in Covid-19 Era. Rathi SK; Dsouza JM Indian J Dermatol; 2022; 67(5):552-555. PubMed ID: 36865865 [TBL] [Abstract][Full Text] [Related]
29. Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris. Kaewsanit T; Chakkavittumrong P; Waranuch N J Clin Aesthet Dermatol; 2021 Jun; 14(6):35-41. PubMed ID: 34804354 [TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory effect of Keigai-rengyo-to extract and acupuncture in male patients with acne vulgaris: a randomized controlled pilot trial. Kim KS; Kim YB J Altern Complement Med; 2012 May; 18(5):501-8. PubMed ID: 22594649 [TBL] [Abstract][Full Text] [Related]
31. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population. Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials. Stein Gold LF; Jarratt MT; Bucko AD; Grekin SK; Berlin JM; Bukhalo M; Weiss JS; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A J Drugs Dermatol; 2016 May; 15(5):553-61. PubMed ID: 27168264 [TBL] [Abstract][Full Text] [Related]
33. Acne treatment efficacy of intense pulsed light photodynamic therapy with topical licochalcone A, l-carnitine, and decanediol: A spilt-face, double-blind, randomized controlled trial. Wanitphakdeedecha R; Tavechodperathum N; Tantrapornpong P; Suphatsathienkul P; Techapichetvanich T; Eimpunth S; Manuskiatti W J Cosmet Dermatol; 2020 Jan; 19(1):78-87. PubMed ID: 31587493 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females. Harper JC; Baldwin H; Stein Gold L; Guenin E J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360 [TBL] [Abstract][Full Text] [Related]
35. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older. Tyring SK; Kircik LH; Pariser DM; Guenin E; Bhatt V; Pillai R J Drugs Dermatol; 2018 Oct; 17(10):1084-1091. PubMed ID: 30365589 [TBL] [Abstract][Full Text] [Related]
37. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients. Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705 [TBL] [Abstract][Full Text] [Related]
38. Snail Soothing and Repairing Cream Improves Skin Hydration after Ablative Fractional CO2 Laser: A Split-Face Randomized Double-Blinded Placebo-Controlled Trial. Theerawattanawit C; Promvaranon T; Rerknimitr P; Asawanonda P; Noppakun N; Kumtornrut C Skin Pharmacol Physiol; 2021; 34(5):262-270. PubMed ID: 34038904 [TBL] [Abstract][Full Text] [Related]
39. A randomized double-blind study to assess the effects of silicic acid compared to placebo in patients with mild to moderate acne. Fernandez C; Adamson K; Dale M; Cunliffe WJ J Dermatolog Treat; 2005; 16(5-6):287-94. PubMed ID: 16428147 [TBL] [Abstract][Full Text] [Related]
40. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers. Buzzi M; de Freitas F; Winter M Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]